Cosmos Health (COSM) Buildings (2025 - 2026)

Cosmos Health's (COSM) quarterly Buildings came in at $5.0 million in Q2 2026, down 0.56% quarter-over-quarter from $5.0 million in Q1 2026.

Analysis

Cosmos Health (COSM) Buildings (2025 - 2026) Analysis & Trends

Cosmos Health (COSM) has reported Buildings for 2 consecutive years, with $5.0 million the latest figure, recorded in Q2 2026.

For the quarter ending Q2 2026, Buildings changed N/A year-over-year to $5.0 million; the trailing twelve-month figure through Jun 2026 stood at $5.0 million (changed N/A YoY), and the FY2025 full-year result was $5.3 million, changed N/A from the prior year.
Buildings slipped to $5.0 million in Q2 2026 per COSM's latest filing, from $5.0 million in the prior quarter.
Across five years, Buildings topped out at $5.3 million in Q4 2025 and bottomed at $5.0 million in Q2 2026.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	42.33 Bn	38.68 Bn	2.15 Bn
2	Viatris	19.05 Bn	18.16 Bn	1.46 Bn
3	Dr Reddys Laboratories	9.76 Bn	9.58 Bn	396.53 Mn
4	Amneal Pharmaceuticals	5.38 Bn	5.25 Bn	334.51 Mn
5	Bausch Health Companies	2.27 Bn	436.38 Mn	2.10 Bn
6	Alvotech	1.51 Bn	1.37 Bn	2.56 Mn
7	Ani Pharmaceuticals	1.51 Bn	1.15 Bn	165.89 Mn
8	Amphastar Pharmaceuticals	1.03 Bn	737.26 Mn	93.47 Mn
9	Fennec Pharmaceuticals	393.12 Mn	351.87 Mn	17.15 Mn
10	Cosmos Health	15.08 Mn	12.63 Mn	1.51 Mn

Historic Data

Download Data